Watching a video before your first eye injection
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether watching a short video before your first eye injection helps you feel more at ease. It is for people who have never had this injection before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- This must be your first treatment with an anti-VEGF injection for a retinal condition.
- You are able to understand and communicate with the study team.
- You are willing to sign a consent form to participate.
- You have not had any eye surgery in the past.
- Your better eye has vision of 0.3 (20/40) or better.
- The eye to be treated does not have a type of severe glaucoma caused by new blood vessels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial tests whether BBC1501, an injection given into the eye, is safe for people with wet age-related macular degeneration (nAMD). It mainly looks at side effects and whether the study injections can be given safely in patients who still have active disease despite prior anti-VEGF treatments.
This trial tests a new eye-numbing gel against the standard numbing method to see which works better for patients getting regular anti-VEGF injections in the eye.
This study looks at how eye pressure changes right after an eye injection. It aims to help doctors better understand and manage pressure spikes after treatment.
This study checks if repeated anti-VEGF eye injections, used to treat retinal diseases, can cause the upper eyelid to droop. It follows people getting their first injection in one eye and watches for eyelid changes.
This trial tests a new eye injection (GenSci148) for people with wet age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. The injection may help reduce swelling and abnormal blood vessel growth in the retina, which can improve or stabilise vision.
This study compares how well an artificial intelligence (AI) program decides on anti-VEGF eye injections versus a doctor's decision for conditions like wet macular degeneration, diabetic macular edema, and retinal vein occlusion. If you've already finished your initial loading doses, participating could help show whether AI can guide your future treatment.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.